Research programme: adenosine A1 receptor antagonists - Endacea
Alternative Names: L-97-1Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Endacea
- Class Small molecules
- Mechanism of Action Adenosine A1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease; Gram-negative infections; Reperfusion injury
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Allergic-rhinitis in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Chronic-obstructive-pulmonary-disease in USA (PO)